Multiple facets of the DNA damage response contribute to the radioresistance of mouse mesenchymal stromal cell lines
- PMID: 22961695
- DOI: 10.1002/stem.1222
Multiple facets of the DNA damage response contribute to the radioresistance of mouse mesenchymal stromal cell lines
Abstract
The regeneration of the hematopoietic system following total body irradiation is supported by host-derived mesenchymal stromal cells (MSCs) within the bone marrow. The mechanisms used by MSCs to survive radiation doses that are lethal to the hematopoietic system are poorly understood. The DNA damage response (DDR) represents a cohort of signaling pathways that enable cells to execute biological responses to genotoxic stress. Here, we examine the role of the DDR in mediating the resistance of MSCs to ionizing radiation (IR) treatment using two authentic clonal mouse MSC lines, MS5 and ST2, and primary bulk mouse MSCs. We show that multiple DDR mechanisms contribute to the radio-resistance of MSCs: robust DDR activation via rapid γ-H2AX formation, activation of effective S and G(2)/M DNA damage checkpoints, and efficient repair of IR-induced DNA double-strand breaks. We show that MSCs are intrinsically programmed to maximize survival following IR treatment by expressing high levels of key DDR proteins including ATM, Chk2, and DNA Ligase IV; high levels of the anti-apoptotic, Bcl-2 and Bcl-(XL); and low levels of the pro-apoptotic, Bim and Puma. As a result, we demonstrate that irradiated mouse MSCs withstand IR-induced genotoxic stress, continue to proliferate, and retain their capacity to differentiate long-term along mesenchymal-derived lineages. We have shown, for the first time, that the DDR plays key roles in mediating the radioresistance of mouse MSCs which may have important implications for the study and application of MSCs in allogeneic bone marrow transplantation, graft-versus-host disease, and cancer treatment.
Copyright © 2012 AlphaMed Press.
Similar articles
-
Hypoxia enhances the radioresistance of mouse mesenchymal stromal cells.Stem Cells. 2014 Aug;32(8):2188-200. doi: 10.1002/stem.1683. Stem Cells. 2014. PMID: 24578291
-
Terminally differentiated astrocytes lack DNA damage response signaling and are radioresistant but retain DNA repair proficiency.Cell Death Differ. 2012 Apr;19(4):582-91. doi: 10.1038/cdd.2011.129. Epub 2011 Oct 7. Cell Death Differ. 2012. PMID: 21979466 Free PMC article.
-
Activation of the phosphorylation of ATM contributes to radioresistance of glioma stem cells.Oncol Rep. 2013 Oct;30(4):1793-801. doi: 10.3892/or.2013.2614. Epub 2013 Jul 11. Oncol Rep. 2013. PMID: 23846672
-
The role of the DNA damage response mechanisms after low-dose radiation exposure and a consideration of potentially sensitive individuals.Radiat Res. 2010 Dec;174(6):825-32. doi: 10.1667/RR1844.1. Epub 2010 Aug 25. Radiat Res. 2010. PMID: 20738172 Review.
-
The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.Adv Cancer Res. 2010;108:73-112. doi: 10.1016/B978-0-12-380888-2.00003-0. Adv Cancer Res. 2010. PMID: 21034966 Review.
Cited by
-
Msl2 is a novel component of the vertebrate DNA damage response.PLoS One. 2013 Jul 9;8(7):e68549. doi: 10.1371/journal.pone.0068549. Print 2013. PLoS One. 2013. PMID: 23874665 Free PMC article.
-
Platelet factor 4 protects bone marrow mesenchymal stem cells from acute radiation injury.Br J Radiol. 2014 Aug;87(1040):20140184. doi: 10.1259/bjr.20140184. Epub 2014 Jun 12. Br J Radiol. 2014. PMID: 24922360 Free PMC article.
-
The response of human mesenchymal stem cells to internal exposure to tritium β-rays.J Radiat Res. 2019 Jul 1;60(4):476-482. doi: 10.1093/jrr/rrz037. J Radiat Res. 2019. PMID: 31165153 Free PMC article.
-
Induction and assessment of persistent radioresistance in murine leukocytes in vivo.Biochem Biophys Rep. 2022 Jun 7;31:101296. doi: 10.1016/j.bbrep.2022.101296. eCollection 2022 Sep. Biochem Biophys Rep. 2022. PMID: 35707716 Free PMC article.
-
NVP-BSK805, an Inhibitor of JAK2 Kinase, Significantly Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma in vitro and in vivo.Drug Des Devel Ther. 2020 Feb 24;14:745-755. doi: 10.2147/DDDT.S203048. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32158193 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous